Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Postgrad Med ; 121(5): 140-4, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19820282

ABSTRACT

Recognition of the prevalence of mood disorders and increased availability of medication options have led to calls for treating bipolar disorders in the primary care setting. Second-generation antipsychotic medications (SGAs) were initially lauded for treating bipolar disorders because of their efficacy and perceived safety relative to first-generation antipsychotic medications. Metabolic syndrome is a constellation of risk factors for cardiovascular disease and type 2 diabetes mellitus, which may emerge when treating bipolar disorders with SGAs. We conducted a search of the research literature examining the association between different SGAs and metabolic syndrome. Based on our review, we offer guidelines for monitoring patient status regarding metabolic syndrome and for providing interventions to promote healthy diet and exercise.


Subject(s)
Antipsychotic Agents/adverse effects , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Bipolar Disorder/epidemiology , Metabolic Syndrome/chemically induced , Metabolic Syndrome/epidemiology , Primary Health Care/methods , Adult , Chronic Disease , Comorbidity , Drug Interactions , Drug Therapy, Combination , Female , Humans , Male , Medication Adherence , Metabolic Syndrome/drug therapy , Prevalence , Risk Management
SELECTION OF CITATIONS
SEARCH DETAIL
...